All20212020 December 21, 2020Janux CEO to Present at H.C. Wainwright Virtual BIOCONNECT 2021 Virtual ConferenceDecember 17, 2020Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T-Cell Engager (TRACTr) Technology
